Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reduction of cardiotoxicity of an antitumor agent using manganese compound

Reduction of cardiotoxicity of an antitumor agent using manganese compound

US Patent 6147094 · Granted Nov 14, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of non-transition metal coordinated dipyridoxyl compounds to prevent and tre2021
Use of non-transition metal coordinated dipyridoxyl compounds to prevent and tre2021
Magnetic resonance imaging2020
Pharmaceutical compositions and therapeutic methods employing a combination of a2020
Spectacles for light therapy2019
Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods2018
Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods2017
Apparatus and method for formation of an energized ophthalmic device for light t2016
Light therapy system including spectacle frames and contact lenses2016
Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods2015
Compounds for use in the treatment of cancer2014
Compounds for use in the treatment of cancer2013